Table 3: Outcomes among diabetic patients followed at baseline and 6, 12, 18 and 24 months.

 

Baseline

6 months

12 months

18 months

24 months

Number of patients with enough time between enrollment and study end to be included

544

517

478

423

394

Alive and in care, by end of milestone (n, %)

544

100%

475

91.9%

415

86.8%

357

84.4%

316

80.2%

If Alive, No. with HbA1c tested

70

29

57

64

64

Median HbA1c

10.3 (8.3-11.9)

8.5 (6.0-11.0)

8.2 (6.1-10.2)

8.4 (6.7-9.6)

8.6 (6.5-10.2)

If Alive, No. with HbA1c tested and baseline HbA1c 10

38

4

9

5

2

Median HbA1c

12.0 (11.2-13.0)

8.2 (6.0-10.4)

8.1 (5.9-11.0)

9.3 (9.1-10.1)

7.7 (6.9-8.5)

Died, by end of milestone (out of those with sufficient follow up) (n, %)

N/A

5

1.0%

8

1.7%

14

3.3%

12

3.0%

Lost to follow up, by end of milestone (n, %)

N/A

37

7.2%

55

11.5%

52

12.3%

66

16.8%

 

Hba1c measured in the following windows: baseline: 0-3 months; 6 months: 4-6 months; 12 months: 7-12 months; 18 months: 13-18 months; 24 months: 19-24 months